Mastery EAQ Ch. 30

A  Desmopressin

B  Octreotide

C  Corticotropin

D  Somatropin

A  Somatropin

B  Octreotide

C  Vasopressin

D  Desmopressin

A  “Skip the missed dose and resume your usual dosage schedule.”

B  “You can take the dose immediately when you remember it.”

C  “You should consult your primary health care provider immediately.”

D  “If it is almost time for your next dose, take a double dose of the drug at that time.”

A  Cosyntropin

B  Desmopressin

C  Somatropin

D  Vasopressin

A  Abdominal stress

B  Drowsiness

C  Vertigo

D  Bleeding gums

A  “Heat the medicine before administration.”

B  “Do not administer the drug to the patient.”

C  “Shake the medication before administration.”

D  “Keep the bottle in warm water before administration.”

A  Encourage vigorous exercise.

B  Monitor blood glucose levels closely.

C  Monitor fluid status.

D  Evaluate the patient for limping.

A  Administering the vasopressin intravenously

B  Monitoring the patient in an intensive care unit

C  Co-administering carbamazepine

D  Obtaining liver and renal function tests

A  Bleeding gums

B  Limping

C  Excessive thirst

D  Abdominal cramps

A  Low blood pressure, Blood glucose elevation, Headache, Low urine output

B  Headache, Low urine output, Low blood pressure, Nausea

C  Nausea, Blood glucose elevation, Headache, Low blood pressure

D  Nausea, Blood glucose elevation, Headache, Low urine output

A  Octreotide subcutaneous

B  Vasopressin nasal spray

C  Desmopressin intravenously

D  Somatropin intramuscular

A  Blood glucose

B  Liver enzymes

C  Electrocardiogram (ECG)

D  Renal panel

A  Radiology report identifies no fracture with closed growth plates.

B  Reports episodic muscle pain during the past year.

C  Previous somatropin injection site tender to touch.

D  Growth percentile has increased from the previous annual physical.

A  Calculate the dosage with the pharmacist or another nurse

B  Review the frequency with the health care provider

C  Review current laboratory values for blood glucose

D  Obtain baseline weight and height measurements

A  Inquire about abdominal discomfort

B  Monitor for signs of infiltration

C  Notice increase in body temperature

D  Assess the patient for headaches

A  Weight gain, Edema of the extremities

B  Increased urination, Thirst

C  Edema of the extremities, Elevated blood pressure

D  Elevated blood pressure, Weight gain

A  Watch the IV site closely for infiltration.

B  Make a note of the fluid intake.

C  Measure the patient’s urine output regularly.

D  Assess for signs of dehydration.

A  Small-bowel fistula and having an acute asthma attack

B  Acromegaly and a serum creatinine level of 5.0 mg/dL

C  Carcinoid tumor-secreting vasoactive intestinal peptide (VIP)

D  Esophageal varices and a history of type 2 diabetes

A  1. Clear the nasal passages.
2. Prime the pump by pressing down four times.
3. Place the spray nozzle in the nostril.
4. Give half a spray in each nostril.
5. Replace the cap on the bottle.
6. Monitor the level of drug left in the pump.

B  1. Clear the nasal passages.
2. Prime the pump by pressing down four times.
3. Place the spray nozzle in the nostril.
4. Give half a spray in each nostril.
5. Monitor the level of drug left in the pump.
6. Replace the cap on the bottle.

C  1. Clear the nasal passages.
2. Prime the pump by pressing down four times.
3. Place the spray nozzle in the nostril.
4. Replace the cap on the bottle.
5. Give half a spray in each nostril.
6. Monitor the level of drug left in the pump.

D  1. Clear the nasal passages.
2. Give half a spray in each nostril.
3. Place the spray nozzle in the nostril.
4. Prime the pump by pressing down four times.
5. Replace the cap on the bottle.
6. Monitor the level of drug left in the pump.

A  Patient A: esophageal varices; type 1 diabetes

B  Patient B: carcinoid tumor; taking ciprofloxacin

C  Patient D: VIP; severe diarrhea and flushing; renal impairment

D  Patient C: VIP; life-threatening hypotension; diarrhea and flushing

A  Joint pain, Fatigue

B  Fatigue, Headache

C  Diarrhea, Flushing

D  Headache, Joint pain

A  The patient needs to adjust fluid intake.

B  The patient is stable and needs reassurance.

C  A higher dose of medication is required for treatment.

D  The medication is not effective for this condition.

A  Storing the pump at room temperature

B  Inhaling the medication into the airway

C  Priming the pump each week

D  Administering half the dose in each nostril

A  “Is there any change in the color of your urine?”
“Is there any change in the color of your sputum?”

B  “Do you have excessive bleeding due to minor injuries?”
“Is there any change in the color of your urine?”

C  “Is there any change in the color of your sputum?”
“Do you have excessive bleeding due to minor injuries?”

D  “Do you feel very thirsty lately?”
“How many times do you urinate in a day?”

A  Height, Weight, Motor skills

B  Motor skills, Visual acuity, Skin turgor

C  Weight, Skin turgor, Visual acuity

D  Skin turgor, Height, Visual acuity

A  Replacing the cap on the pump after the procedure

B  Pressing the pump once to spray a 10-mcg dose

C  Pressing down on the pump two times to prime it

D  Priming the nasal pump once a week

A  Hypothyroidism

B  Hyperglycemia

C  Hypertension

D  Hypercalciuria

A  “Inhale the drug preparation by spraying into the nostrils.”

B  “Dilute the drug preparation before administration.”

C  “Apply the drug preparation topically to the nasal membranes.”

D  “Shake the drug preparation thoroughly before use.”

A  Watery diarrhea

B  Abundant, diluted urine

C  Loss of consciousness

D  Oozing blood

A  Cachexia and closed growth plates

B  Human immunodeficiency virus (HIV) infection

C  Acute bronchitis with laryngitis

D  Bilateral metastatic breast cancer

A  A 10-year-old of short stature who has severe asthma

B  An 8-year-old with a pituitary tumor

C  A 17-year-old who is 5 feet tall

D  A 7-year-old diagnosed with growth hormone deficiency

A  Desmopressin and carbamazepine

B  Vasopressin and demeclocycline

C  Vasopressin and carbamazepine

D  Somatropin and glucocorticoids

A  Edema

B  Heartburn

C  Seizures

D  Hypoglycemia

A  Orthostatic hypotension

B  Hyponatremia

C  Hyperglycemia

D  Hypokalemia

A  Ciprofloxacin

B  Glucocorticoids

C  Cyclosporine

D  Fludrocortisone

A  Diabetes insipidus, Seizure, Type I von Willebrand

B  Asthma, Diabetes insipidus, Type I von Willebrand

C  Cardiovascular disease, Diabetes insipidus, Type I von Willebrand

D  Seizure, Asthma, Cardiovascular disease

A  Decreases growth

B  Reduces fat levels

C  Reduces weight loss

D  Decreases fluid retention

A  Low blood sugar levels, Increased lipid mobilization, Retention of potassium levels

B  Increased lipid mobilization, Increased retention of sodium, Improved tissue-building processes

C  Low blood sugar levels, Retention of potassium levels, Increased retention of sodium

D  Improved tissue-building processes, Low blood sugar levels, Retention of potassium levels

A  Carbamazepine

B  Thioridazine

C  Acetaminophen

D  Norepinephrine

A  Renal function studies, Liver enzyme levels, Blood pressure

B  Weight, Blood pressure, Blood glucose levels

C  Liver enzyme levels, Blood glucose levels, Renal function studies

D  Liver enzyme levels, Renal function studies, Weight

A  Dyspnea, Constipation, Hypercalciuria

B  Arthralgia, Hypercalciuria, Constipation

C  Constipation, Malaise, Hypercalciuria

D  Malaise, Dyspnea,

A  Hypotension

B  Scar formation

C  Edema

D  Inflammation

A  Produces an additive effect

B  Reduces the effects of desmopressin

C  Causes prolongation of QT interval

D  Enhances the effects of desmopressin

A  Octreotide

B  Desmopressin

C  Vasopressin

D  Somatropin

A  Somatropin

B  Cosyntropin

C  Desmopressin

D  Octreotide

A  Polyuria

B  Polydipsia

C  Dehydration

D  Headache

A  Octreotide

B  Oxytocin

C  Thyroid hormone

D  Cosyntropin

A  Ciprofloxacin

B  Demeclocycline

C  Carbamazepine

D  Cyclosporine

A  Blood glucose level

B  Creatinine clearance test

C  Complete blood count result

D  Uric acid level

A  Vasopressin

B  Desmopressin

C  Somatropin

D  Luteinizing hormone

A  Hypopituitary dwarfism

B  Polydipsia

C  Acromegaly

D  Polyuria

A  Oxytocin

B  Octreotide

C  Cosyntropin

D  Vasopressin

A  Somatropin

B  Choriomammotropin

C  Somatolactin

D  Somatostatin

A  Adrenocorticotropic hormone (ACTH), Aldosterone, Thyrotropin-releasing hormone (TRH)

B  Thyroxine, Aldosterone, Thyrotropin-releasing hormone (TRH)

C  Thyroxine, Thyroid-stimulating hormone (TSH), Thyrotropin-releasing hormone (TRH)

D  Growth hormone (GH), Thyroid-stimulating hormone (TSH), Adrenocorticotropic hormone (ACTH)

A  Increased serum albumin levels

B  Decreased adrenocorticotropic hormone levels

C  Relief of pain

D  Increased urine specific gravity